News
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...
KEY TAKEAWAYS U.S. equities were mixed at midday after China accused the U.S. of violating a trade deal the two countries ...
Arguably the most notable of the FDA’s upcoming decisions is that regarding Gilead’s twice-yearly HIV prophylaxis lenacapavir ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback